Here are relevant reports on : diagnostic-disinfectant-market
-
Neurodiagnostics Market by Product (Diagnostic & Imaging Systems (MRI, Ultrasound), Clinical Testing (PCR, NGS), Reagents & Consumables), Disease Pathology (Epilepsy, Stroke), End User and Region - Global Forecasts to 2024
The neurodiagnostics market is projected to reach USD 8.4 billion by 2024, at a CAGR of 7.3%. Some of the prominent players in this market includes GE Healthcare (US), Siemens Healthineers (Germany), Philips Healthcare (Netherlands), Hitachi, Ltd. (Japan), Canon, Inc. (Japan), Lifelines Neuro Company, LLC (US), Natus Medical Incorporated (US), Hoffman-La Roche AG (Switzerland), FUJIFILM Holdings Corporation (Japan), Mitsar Co., Ltd. (Russia), Advanced Brain Monitoring (US), Thermo Fisher Scientific, Inc. (US), Bio-Rad Laboratories (US), QIAGEN N.V. (Netherlands), Nihon Kohden Corporation (Japan), ANT Neuro (Netherlands), Fonar Corporation (US), Fujirebio (Japan), DRG Instruments GmbH (Germany), Tecan Trading AG (Switzerland), Motion Lab Systems, Inc. (US), Rigaku Corporation (Japan), Neusoft Medical Systems Co., Ltd. (US), ELMIKO MEDICAL Sp. Z o.o. (Poland) and Ridge Diagnostics (US).
- Published: December 2019
- Price: $ 4950
- TOC Available:
-
E.coli Test Market by test (Environmental (Membrane Filtration, Multiple Tube Fermentation), Clinical (Polymerase Chain Reaction, Enzyme Immunoassays)) End User (Hospital, Diagnostic Laboratories, Physician Offices) - Global Forecasts to 2023
The global E.coli test market is expected to reach USD 2.05 billion by 2023 from USD 1.38 billion in 2018, growing at a CAGR of 8.2%. Increasing awareness regarding hygienic, government regulations regarding water and food management, government funding for performing diagnostic tests, non-government organizations (NGO’s) campaigns on water management, increasing prevalence of diarrhoea cases are the major driving factors for this market.
- Published: March 2026
- Price: $ 4950
- TOC Available:
-
Medical Image Management Market by Product (PACS (Departmental, Radiology, Mammography, Cardiology, Enterprise), VNA (On-premise, Hybrid, Cloud), AICA, Universal Viewer), End User (Hospitals, Diagnostic Imaging Centers, ASC, CRO) - Global Forecast to 2023
The medical image management market is projected to reach USD 4.40 billion in 2023, growing at a CAGR of 7.7% . Prominent players in this market include McKesson Corporation (US), GE Healthcare (US), Fujifilm Holdings Corporation (Japan), Merge Healthcare Inc. (US), Agfa-Gevaert Group (Belgium), Philips Healthcare (Netherlands), Siemens Healthineers (Germany), Carestream Health, Inc. (US), BridgeHead Software (UK), Novarad Corporation (US), Mach7 Technologies Ltd. (US), and INFINITT Healthcare Co., Ltd.(South Korea).
- Published: August 2018
- Price: $ 4950
- TOC Available:
-
European Medical Devices Market by Type (Diagnostic Imaging, Endoscopy Equipment, Respiratory Care, Cardiac Monitoring Devices, Haemodialysis Devices, Ophthalmic Devices, Anesthesia Monitoring), End User (Hospitals, Home-care) & Region - Global Forecast to 2025
European medical devices market growth is primed to transition from $48.9 billion in 2020 to $61.4 billion by 2025, showcasing a strong CAGR of 4.7%. Key growth drivers include an aging population, advancements in medical technology, and an increasing number of surgical procedures, alongside the need for cost containment in healthcare.
- Published: May 2020
- Price: $ 4950
- TOC Available:
-
Vascular Imaging Market by Technology (MRI, Ultrasound, CT, Hybrid, OCT), Application (Atherosclerosis, DVT, Vasculitis, Aneurysmal Disorders, AV Malformations, Tumours, Others), End User (Hospitals, Diagnostic Imaging Centers) - Global Forecast to 2030
The global vascular imaging market, valued at US$3.03 billion in 2024, stood at US$3.21 billion in 2025 and is projected to advance at a resilient CAGR of 7.8% from 2024 to 2030, culminating in a forecasted valuation of US$4.67 billion by the end of the period. The growth of the vascular imaging market is driven by the rising prevalence of cardiovascular diseases, including atherosclerosis, peripheral artery disease, and stroke, which demand early diagnosis and monitoring.
- Published: November 2025
- Price: $ 4950
- TOC Available:
-
Meat Speciation Testing Market by Species (Bos Taurus, Sus Scrofa, Gallus Gallus, Equus Caballus, Ovis Aries), Technology (PCR, ELISA, Molecular Diagnostic), Form (Raw, Cooked, Processed), and Region - Global Forecast to 2022
The meat speciation testing market is projected to grow at a CAGR of 8.20% from 2016 to 2022, to reach a projected value of USD 2,220.6 Million by 2022. The market is driven by increase in number of adulteration and food fraud cases, religious beliefs, and compliance with labeling laws, and stringent regulations and consumer demand for certified products.
- Published: January 2017
- Price: $ 4950
- TOC Available:
-
Single Cell Sequencing Market by Product (Reagents & Kits, Platforms, Software), Workflow (Presequencing), Service (Sample Preparation, Bioinformatics), Sequencing (scRNA, scDNA), Application (Research, Diagnostic), End User - Global Forecast to 2030
The global Single Cell Sequencing market, valued at US$1.89 billion in 2024, stood at US$1.95 billion in 2025 and is projected to advance at a resilient CAGR of 12.2% from 2025 to 2030, culminating in a forecasted valuation of US$3.46 billion by the end of the period. This growth is driven by advancements in single-cell workflow, including more efficient cell isolation methods, improved library preparation kits, and high-throughput, cost-effective sequencing platforms.
- Published: July 2025
- Price: $ 4950
- TOC Available:
-
Digital Mammography Market by Technology (2D FFDM, 3D FFDM, CEDM), Product (Digital Mammography System, Display Unit, CPUS, Visualization Software), End User (Hospitals, Breast Care Centers, Diagnostic Centers) - Global Forecasts to 2030
The global digital mammography market is projected to reach USD 3.05 billion by 2030 from USD 1.35 Billion in 2022, at a CAGR of 10.5% during the forecast period. The technological advancements majorly drive the growth in the digital mammography market in the field of mammography coupled with greater integration of digital & AI tools with imaging workflow, growing screening tests for breast cancer, and increasing funding initiatives from public/private organizations to create awareness for breast cancer screening.
- Published: March 2026
- Price: $ 4950
- TOC Available:
-
Precision Diagnostics & Medicine Market by Diagnostic Testing (Genetic, DTC), Diagnostics Indication (Oncology, Neurology, Immunology), Therapeutic Products (Inhibitors, mAbs, CGT), Indication (Oncology, Rare Disease, Infectious) - Global Forecast to 2029
The global precision diagnostics and medicine market, valued at US$132.46 billion in 2023, stood at US$145.53 billion in 2024 and is projected to advance at a resilient CAGR of 11.1% from 2024 to 2029, culminating in a forecasted valuation of US$246.66 billion by the end of the period. Factors such as the growing integration of AI and ML to enhance precision diagnostics and medicine development supported by rising collaborations between pharmaceutical and diagnostics companies to improve precision healthcare and the rise in direct-to-consumer testing are driving the growth in the market.
- Published: January 2025
- Price: $ 4950
- TOC Available:
-
Ophthalmic Equipment Market by Technology (AI-enabled Equipment), Product Type (Surgical Devices (Ophthalmic Microscopes), Diagnostic & Monitoring Devices (Optical Coherence Tomography Scanners, Slit Lamps) ), End User (Hospitals) - Global Forecast to 2030
The global ophthalmic equipment market, valued at US$18.61 billion in 2024, stood at US$19.65 billion in 2025 and is projected to advance at a resilient CAGR of 5.9% from 2024 to 2030, culminating in a forecasted valuation of US$26.14 billion by the end of the period.
- Published: November 2025
- Price: $ 7150
- TOC Available:
Records 21 to 30 of 50
